• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素和红霉素在小鼠体内的自显影研究。

Autobacteriographic studies of clarithromycin and erythromycin in mice.

作者信息

Kohno Y, Ohta K, Suwa T, Suga T

机构信息

Research Center, Taisho Pharmaceutical Co., Ltd., Ohmiya, Japan.

出版信息

Antimicrob Agents Chemother. 1990 Apr;34(4):562-7. doi: 10.1128/AAC.34.4.562.

DOI:10.1128/AAC.34.4.562
PMID:2140497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171644/
Abstract

The antimicrobial activity of clarithromycin was compared with that of erythromycin in experimentally infected mice by whole-body autobacteriography. In mice with systemic staphylococcal infections, the number of vital microbes in the body was relatively low in the early period after oral administration of erythromycin, but increased thereafter to the levels found in nonmedicated control mice. On the other hand, with clarithromycin treatment, a significantly smaller number of microbes was evident throughout the body. The microbes were scarcely seen in the parenchyma of any organs during the examination period. This potent antimicrobial activity of clarithromycin compared with that of erythromycin was further demonstrated in mice with respiratory infections. On the other hand, to examine the distribution properties of both antibiotics in the whole body, an autoradiographic study was carried out with [N-methyl-14C]clarithromycin and [N-methyl-14C]erythromycin. Both labeled antibiotics were distributed widely throughout the body after oral administration in both uninfected control mice and mice with systemic infections. However, the radioactivity was more marked and persistent for [14C]clarithromycin than it was for [14C]erythromycin, particularly in the lungs. The observations described above indicate the superior in vivo antimicrobial activity of clarithromycin compared with that of erythromycin and suggest that the superiority of clarithromycin is largely attributed to its favorable distribution properties. The advantages of whole-body autobacteriography, coupled with whole-body autoradiography, are discussed.

摘要

通过全身自显影术,比较了克拉霉素与红霉素在实验性感染小鼠体内的抗菌活性。在患有全身性葡萄球菌感染的小鼠中,口服红霉素后早期体内存活微生物数量相对较低,但此后增加到未用药对照小鼠的水平。另一方面,用克拉霉素治疗时,全身可见的微生物数量明显较少。在检查期间,任何器官的实质中几乎都看不到微生物。在患有呼吸道感染的小鼠中,进一步证明了克拉霉素与红霉素相比具有更强的抗菌活性。另一方面,为了研究两种抗生素在全身的分布特性,用[甲基-14C]克拉霉素和[甲基-14C]红霉素进行了放射自显影研究。在未感染的对照小鼠和患有全身性感染的小鼠中,口服给药后两种标记抗生素均广泛分布于全身。然而,[14C]克拉霉素的放射性比[14C]红霉素更明显且持续时间更长,尤其是在肺部。上述观察结果表明,克拉霉素在体内的抗菌活性优于红霉素,并表明克拉霉素的优势很大程度上归因于其良好的分布特性。讨论了全身自显影术与全身放射自显影术相结合的优点。

相似文献

1
Autobacteriographic studies of clarithromycin and erythromycin in mice.克拉霉素和红霉素在小鼠体内的自显影研究。
Antimicrob Agents Chemother. 1990 Apr;34(4):562-7. doi: 10.1128/AAC.34.4.562.
2
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats.新型大环内酯类抗生素克拉霉素(TE - 031)与红霉素在大鼠体内的比较药代动力学
Antimicrob Agents Chemother. 1989 May;33(5):751-6. doi: 10.1128/AAC.33.5.751.
3
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
J Antibiot (Tokyo). 1995 Oct;48(10):1141-7. doi: 10.7164/antibiotics.48.1141.
4
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.克拉霉素:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1992 Jul;44(1):117-64. doi: 10.2165/00003495-199244010-00009.
5
Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.
J Antibiot (Tokyo). 1990 Mar;43(3):295-305. doi: 10.7164/antibiotics.43.295.
6
New macrolide antibiotics: clarithromycin and azithromycin.新型大环内酯类抗生素:克拉霉素和阿奇霉素。
Am Fam Physician. 1992 Sep;46(3):863-9.
7
Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
Drugs Exp Clin Res. 1988;14(7):441-4.
8
Azithromycin and clarithromycin: overview and comparison with erythromycin.阿奇霉素和克拉霉素:概述及与红霉素的比较
Infect Control Hosp Epidemiol. 1992 Jun;13(6):357-68. doi: 10.1086/646545.
9
Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
J Antimicrob Chemother. 1991 Feb;27 Suppl A:31-41. doi: 10.1093/jac/27.suppl_a.31.
10
Uptake of clarithromycin by rat lung cells.大鼠肺细胞对克拉霉素的摄取。
J Antimicrob Chemother. 1990 Oct;26(4):503-13. doi: 10.1093/jac/26.4.503.

引用本文的文献

1
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.在小鼠肺部感染模型中,大环内酯类药物敏感性对克拉霉素和阿奇霉素抗肺炎链球菌疗效的影响。
Antimicrob Agents Chemother. 2003 Feb;47(2):739-46. doi: 10.1128/AAC.47.2.739-746.2003.
2
Clarithromycin clinical pharmacokinetics.克拉霉素的临床药代动力学。
Clin Pharmacokinet. 1993 Sep;25(3):189-204. doi: 10.2165/00003088-199325030-00003.
3
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses.

本文引用的文献

1
Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A.红霉素的化学修饰。I. 6-O-甲基红霉素A的合成及抗菌活性
J Antibiot (Tokyo). 1984 Feb;37(2):187-9. doi: 10.7164/antibiotics.37.187.
2
The localization of Staphylococcus aureus in mice by whole-animal radioautography.通过全动物放射自显影术对小鼠体内金黄色葡萄球菌的定位
Am J Pathol. 1966 Jan;48(1):149-63.
3
[A new technique for detection of microbes in the body and for chemotherapeutic evaluation of antibacterial agents: whole body bacterioautography].
新型大环内酯类药物克拉霉素单次递增口服剂量后的药代动力学
Antimicrob Agents Chemother. 1992 Nov;36(11):2447-53. doi: 10.1128/AAC.36.11.2447.
4
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.克拉霉素:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1992 Jul;44(1):117-64. doi: 10.2165/00003495-199244010-00009.
Yakugaku Zasshi. 1969 Dec;89(12):1740-1. doi: 10.1248/yakushi1947.89.12_1740.
4
[The whole body autobacteriographic studies on the distribution of Staphylococcus aureus in mice].
Yakugaku Zasshi. 1970 Sep;90(9):1100-6. doi: 10.1248/yakushi1947.90.9_1100.
5
Detection of Erysipelothrix insidiosa in mice by whole body autobacteriography.
Natl Inst Anim Health Q (Tokyo). 1973 Summer;13(2):54-8.
6
[Experimental Pseudomonas pneumonia model in normal mice].
Kansenshogaku Zasshi. 1986 Nov;60(11):1165-71. doi: 10.11150/kansenshogakuzasshi1970.60.1165.
7
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.新型大环内酯类抗生素A-56268(TE-031)与红霉素及其他抗菌药物的体外活性比较
Antimicrob Agents Chemother. 1987 Apr;31(4):640-2. doi: 10.1128/AAC.31.4.640.
8
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.Ro 15 - 8074、Ro 19 - 5247、A - 56268及罗红霉素(RU 28965)对淋病奈瑟菌和沙眼衣原体的体外活性。
Antimicrob Agents Chemother. 1987 Mar;31(3):470-2. doi: 10.1128/AAC.31.3.470.
9
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria.A-56268与红霉素及其他口服制剂针对需氧菌和厌氧菌的活性比较。
Antimicrob Agents Chemother. 1987 Mar;31(3):463-6. doi: 10.1128/AAC.31.3.463.
10
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.A-56268(TE-031)及其他四种抗菌剂对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1987 Jan;31(1):100-1. doi: 10.1128/AAC.31.1.100.